Tetrazolium salts are known to produce dyes called formazan upon NADH reduction in the presence of an electron mediator, such as phenazinium salt, and have therefore been used in clinical analyses of detecting NADH or NADH-dependent enzyme (dehydrogenase) activities. Among others, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT)1 and 3,3'-[3,3'-dimethoxy-(1,1'-biphenyl)-4,4'-diyl]-bis[2-(4-nitrophenyl)-5-phenyl-2H tetrazolium chloride] (Nitro-TB)2 are most widely used because of their high sensitivity toward NADH. A major disadvantage that limits their applications in clinical assays, however, is that the formazan dyes are so insoluble to water that one has to use a detergent or an organic solvent to maintain the homogeneity of assay solutions. In our continuing efforts to develop tetrazolium salts that produce watersoluble formazan dyes3-5, we recently synthesized novel tetrazolium salts, 2-benzothiazolyl-3-(4-carboxy-2-methoxyphenyl)-5-[4-(2-sulfoethylcarbamoyl)phenyl]-2H-tetrazolium (WST-4, Chart 1) and 2,2'-dibenzothiazolyl-5, 5'-bis[4-di(2-sulf oethyl)carbamoylphenyl]-3, 3'-(3, 3'-dimethoxy-4,4'-biphenylene)ditetrazolium, disodium salt (WST-5, Chart 1); they produce highly water soluble formazan dyes absorbing at a long wavelength (>500 nm). We now report on the synthesis and their applicability as a reagent for the determination of NADH.
Experimental

Apparatus
Thin-layer chromatography (TLC) was performed on Chart Materials Nitro-TB and 1-methoxy-5-methylphenazinium methosulfate (1-methoxy PMS) from Dojindo Laboratories (Kumamoto, Japan) were used without purification. NADH and a-NAD+ were purchased from Oriental Yeast Co., Ltd. (Osaka, Japan). Lactic acid lithium salt of >97% purity (enzymatic assay) was purchased from Sigma (St. Louis, MO, USA). Lactate dehydrogenase isoenzyme (LDH-1 H4, 98+% homogeneous)) from human erythrocytes was also from Sigma as a suspension of a 2.1 M (NH4)2504 solution at pH 6.0. The solutions of WST-4 and 5 were prepared as aqueous solutions at a concentration of 1 mM. Synthesis 4-(2-Sulfoethylcarbamoyl)benzaldehyde.
4-Formylbenzoic acid (30 g, 0.20 mol) in 150 ml of thionyl chloride was refluxed for 2 h. Thionyl chloride was removed under reduced pressure and an oily product was crystallized from hexane to afford 29.0 g of the acid chloride as a white powder. The acid chloride in CHCl3 (200 ml) and 2 M aqueous NaOH (150 ml) were added, dropwise, simultaneously to a pre-cooled solution (0° C) of taurine (17.0 g, 0.14 mol) in a mixture of water and CHC13 (200 ml each). After being stirred for 3 h at room temperature, the aqueous layer was acidified (ca. pH 3) with 0.5 M HCl and filtered. The filtrate was concentrated to about one third of its volume, to which was added isopropanol to prompt crystallization of the product. Yield 
Concentrated HCl (11.6 ml, 0.140 mol) was added to a stirred suspension of 4-amino-3-methoxybenzoic acid (7.8 g, 0.047 mol) in water (70 ml); the solution was cooled to 0° C. To this was added sodium nitrite (3.5 g, 0.051 mol) in water (70 ml) dropwise at 0 -5° C. After being stirred at 5° C for 30 min, the solution was added to a pre-cooled solution of sodium salt of 4-(2-sulfoethylcarbamoyl)benzaldehyde-2'-benzothiazolylhydrazone (17.9 g, 0.042 mol) in a mixture of dimethylformamide and water (180 ml each). Sodium hydroxide (7.5 g, 0.187 mol) in water (180 ml) was added dropwise to the mixture while the temperature was kept at -5 -0° C. The solution was stirred for 2 h at this temperature and for an additional few hours at room temperature. The reaction mixture was acidified (ca. pH 2) with 2 M HCI, and the resulting precipitate was collected. The thus-obtained crude formazan was re-dissolved in 1 M NaOH (500 ml) and acidified as above, yielding 16.1 g (58%) of the product formazan as a dark-blue powder. Concentrated HCl (19.7 ml, 236 mmol) and butyl nitrite (12.2 g, 118 mmol) were sequentially added to a stirred methanol solution (500 ml) of formazan (14.0 g, 23.6 mmol). Stirring was continued for 2 d at room temperature. The resulting precipitate was collected; it then was re-dissolved in a hot mixture of methanol (1000 ml) and water (1000 ml) and treated with activated charcoal. The solution was concentrated to about one forth of its volume, which resulted in a precipitation of the product, WST-4, of 6.4 g (47%) after drying as a yellow powder. To taurine (37.5 g, 0.30 mol) in water (250 ml) was added aqueous NaOH (12.0 g in 150 ml), and the solution was heated to 60° C. Sodium 2-bromoethyl sulfonate (69.6 g, 0.33 mol) in water (250 ml) was added dropwise over a period of 4 h. After being stirred at 60°C for 16 h, aqueous NaOH (12.0 g in 150 ml) was added dropwise over 8 h, while keeping this temperature; the reaction mixture was stirred at 60° C overnight. This solution, which contained the title compound, was used for the next step without purification. 4-[N,R-Di(2-sulfoethyl)carbamoyl]benzaldehyde, disodium salt.
4-Formylbenzoic acid (58.6 g, 0.39 mol) in thionyl chloride (250 ml) was refluxed for 2 h. After thionyl chloride was removed under reduced pressure, the oily residue was crystallized from hexane to afford 54.5 g of the acid chloride as a white powder. The acid chloride in CHCl3 (200 ml) and 2 M NaOH (180 ml) were simultaneously added dropwise to a stirred pre-cooled (0° C) mixture of CHCl3 and water (350 ml each) solution of disodium salt of di(2-sulfoethyl)amine. After 3 h at room temperature, the aqueous layer was acidified (ca. pH 3) with 0.5 M HCI, and filtered. The filtrate was de-salted by using a Micro Acilyzer G3 (Asahikasei Industry, Tokyo, Japan); it was concentrated to a small volume, to which was added methanol (11), resulting in precipitation. After the precipitate was removed by filtration, the filtrate was treated twice in the same manner as mentioned above using a mixture of methanol and isopropanol (5 : A suspension containing 2-hydrazinobenzothiazole (9.7 g, 58.7 mmol) and disodium salt of 4-[N,N'-di(2-sulfoethyl)carbamoyl]benzaldehyde (20.0 g, 48.9 mmol) in methanol (300 ml) was refluxed for 3 h. The resulting precipitate was collected, and chromatographed on Sephadex LH-20 (methanol/ water =l / 1, v/v as eluent) to afford 13.9 g (51%) of the title compound as a yellow powder. mp: >300° C; TLC: Rf=0.20; 1H-NMR (D20) 8: 3.14 (t, 2H, J7.7 Hz, NCH2), 3.32 (t, 2H, J7. 
NADH assay
To a mixture containing a tetrazolium salt (0.1 mM) and 1-methoxy PMS (5 µM) in 5 ml of 50 mM phosphate buffer (pH 8.0), 0 -100 sl of NADH (5 mM) was added to give a final concentration of 0 -100 µM. After the solution was incubated at 22° C for 5 min, the absorbance at 550 nm (for WST-4 or WST-5) was measured against a blank prepared in the same manner without NADH addition.
Assay of lactic acid
To a mixture containing a tetrazolium salt (1 mM),1-methoxy PMS (20 µM) and f3-NAD+ (200 µM) in 5 ml of 100 mM CHES buffer (pH 8.8) was added 0 -50 µl of lactic acid lithium salt (10 mM in water) to give a final concentration of 0 -100 µM. After the solution was pre-incubated at 30° C for 5 mm, 100 µl of LDH (20 U/ ml) was added (final concentration=0.4 U/ml). The solution was incubated at 30° C for 10 min; the absorbance was measured at 550 nm (for WST-4 or WST-5), or 525 nm (for Nitro-TB).
Results and Discussion
Tetrazolium salts that yield formazans with a long absorption wavelength have great potentials as reagents for clinical analyses, since interferences caused by background absorption of other substances in biological samples can be minimized. The longest absorption wavelength so far reported is that of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)6, which absorbs at 565 nm upon NADH reduc-tion, presumably due to the presence of its thiazolyl moiety. WST-4 was designed in order that it produce a highly water-soluble formazan with an absorption at longer than 550 nm because of the benzothiazole group and one sulfonated group that is not conjugated to the tetrazolium nucleus. The dimer analog, WST-5, substituted similarly as WST-4, was synthesized to increase the sensitivity of WST-4 toward NADH.
The synthesis of these tetrazolium salts was carried out in a similar manner as described for tetrazolium salts, reported earlier.3,4 Both formazans were highly water soluble with a solubility greater than 10 mM. Figure 1 shows the change in the absorption spectra of WST-4 (A) and WST-5 (B) in the visible region when they were incubated with various amounts of NADH under the same conditions at pH 8.0. As expected, although both tetrazolium salts gave an almost equal absorption maximum at 550 nm, the increase in the absorbance per amount of NADH (=sensitivity) of WST-5 was 1.3-fold greater than that of WST-4. The broad absorptions of the formazans allows a quantification of NADH, even at a wavelength longer than 600 nm.
The time course of the reductions of WST-4 and WST-5 with an equimolar amount of NADH at pH 8.0 is shown in Fig. 2 . WST-4 was more readily reduced than was WST-5 in the kinetics, being completed within 5 min, as well as in the reaction yield. Indeed, WST-4 was converted to the formazan in 69% yield after 15 min, based on the absorbance (E=1.3X104 at 550 nm), whereas WST-5 was converted in 44% yield (82.7X104 =at 550 mm). The lower conversion yield of WST-5 can be rationalized by the formation of a half-reduced tetrazolium salt. The colors as developed were stable for at least 5 d at room temperature. Figure 3 compares WST-4 and WST-5 in the sensitivity toward NADH (A) and the yield of the formazans (B) at various pH values. The most remarkable here is that the yield of WST-4 drops as the pH increases while that of WST-5 remains relatively constant, although the reason for the decrease is unclear (Fig. 3B) . In contrast, the sensitivity of WST-4 increased with increasing pH values because of a large increase in the e value of the formazan with increasing pH values (data not given). WST-5 did not yield a significant difference between the two pH profiles, and gave constant sensitivity values in a neutral pH range, which is a practical advantage to the method using WST-5. A good linearity of the absorbance to NADH was obtained for these tetrazolium salts with correlation coefficients (r) higher than 0.990 at each pH value.
We finally applied these tetrazolium salts to an assay of lactic acid, which is based on LDH-mediated dehydrogenation of lactic acid to produce pyruvic acid and NADH (Fig. 4) . The sensitivities of WST-4 and WST-5 toward lactic acid, expressed as the increase of absorbance per lactic acid in mM (=the slope in the figure), were 2.6 (r=0.997) and 3.4 (r=0.997), respectively, both of which were lower than that of Nitro-TB (3.9 with r=0.987). The relative standard deviation for WST-4 and WST-5 determined by five separate runs for each point in the figure did not exceed 5%. The relatively poor linearity in the case of Nitro-TB is probably due to a product inhibition at higher lactic acid concentrations, which should lead to a lower sensitivity of the method for determining lactic acid in serum that ranges 0.44 -1.88 mM. The result of the UV method is also shown for a comparison, which measures NADH at its Amax of 340 nm without using the tetrazolium/ formazan system; the sensitivity was 0.4 with r=0.979. Thus, these tetrazolium salts, WST-4 and WST-5, were proved to be useful for NADH assays with high water solubility and longer absorption wavelength of the formazan. 
